Indian stock indices extended losses on Monday, with Sensex and Nifty declining. Broader markets bucked the trend, closing higher as crude ...

2026 Independence Day: India's pharmaceutical industry marks a historic milestone with a new drug approval. This achievement reflects decad...

Indian stock markets experienced a significant surge on Monday. Nifty and Sensex indices both closed higher after positive news emerged. Pr...

Markets extended their winning streak on Friday, supported by encouraging quarterly business updates. Nifty strengthened its bullish struct...

Sun Pharma Q1 Results: Sun Pharma reported a 27% YoY rise in Q1 net profit to Rs 2,895 crore, while revenue grew 10% to Rs 15,300 crore, dr...

Indian markets traded in a narrow range, settling marginally higher with mixed cues. Maruti Suzuki, ITC, and Vedanta shares are in focus du...

Indian stock markets experienced significant declines on Wednesday. Escalating Iran-US tensions and tariff threats spooked investors, causi...

President Donald Trump has given generic drugmakers two years to shift manufacturing to the US or face 100% import tariffs from August 2028...

Dalal Street ended the week on a strong note, with the Sensex and Nifty gaining over 1% on Friday. Investors will track six key market trig...

Indian markets surged for a third straight day, buoyed by global sentiment and strong performance from heavyweight stocks like HDFC Bank an...

Indian stock markets surged on Friday, with Sensex and Nifty climbing over 0.3% each. This rally was fueled by easing Middle East tensions,...

Indian markets ended lower as Sensex and Nifty snapped a two-session winning streak, pressured by geopolitical tensions in the Middle East ...

Indian markets saw a dip on Friday, with IT stocks leading the decline. Analysts suggest profit-taking occurred near the 24,150 mark. Despi...

Sun Pharma Q1 Results: Sun Pharma reported a 40% increase in consolidated net profit to Rs 2,836 crore, surpassing estimates of Rs 2,638 cr...

Concert's lead candidate, deuruxolitinib, is being evaluated as a treatment for autoimmune condition alopecia areata, which results in patc...

The company said during the quarter and year ended March 31, 2022 the company incurred a one-time cost of Rs 56.35 crore in relation to res...

The United States Food and Drug Administration (USFDA) conducted the Good Manufacturing Practices (GMP) inspection of the company's Halol f...